logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Medications for Atrial Flutter

    FiltersReset Filters
    12 results

    • corvert

      (ibutilide fumarate)
      Pharmacia & Upjohn Company LLC
      Usage: CORVERT Injection is indicated for the rapid conversion of recent-onset atrial fibrillation or atrial flutter to sinus rhythm. It is less effective in patients with arrhythmias lasting longer than 90 days, as its effectiveness in such cases has not been established.

    • diltiazem hydrochloride

      (diltiazem hydrochloride)
      Eugia US LLC
      Usage: Diltiazem hydrochloride injection is indicated for the temporary control of rapid ventricular rate in atrial fibrillation or flutter, and for the rapid conversion of paroxysmal supraventricular tachycardia to sinus rhythm. Continuous ECG monitoring is required, particularly during intravenous infusion.

    • diltiazem hydrochloride

      (Diltiazem Hydrochloride)
      Hikma Pharmaceuticals USA Inc.
      Usage: Diltiazem Hydrochloride Injection is indicated for temporary control of rapid ventricular rates in atrial fibrillation or flutter and for converting paroxysmal supraventricular tachycardia (PSVT) to sinus rhythm. Continuous monitoring is essential during administration, with emergency equipment on hand.

    • dofetilide

      (Dofetilide)
      VGYAAN Pharmaceuticals LLC
      Usage: Dofetilide Capsules are indicated for maintaining normal sinus rhythm and delaying recurrence of atrial fibrillation/atrial flutter in symptomatic patients who have been converted to sinus rhythm. They are also used for converting atrial fibrillation/flutter to normal sinus rhythm but are ineffective in paroxysmal cases.

    • dofetilide

      (DOFETILIDE)
      NorthStar RxLLC
      Usage: Dofetilide capsules are indicated for maintaining normal sinus rhythm in patients with atrial fibrillation/atrial flutter (AF/AFl) post-conversion and for converting AF/AFl to normal sinus rhythm. It is intended for symptomatic patients and is not effective for paroxysmal AF.

    • dofetilide

      (Dofetilide)
      EXELAN PHARMACEUTICALS, INC.
      Usage: Dofetilide capsules are indicated for maintaining normal sinus rhythm and delaying the recurrence of atrial fibrillation/atrial flutter in symptomatic patients after conversion. They are also used for converting atrial fibrillation/flutter to normal sinus rhythm, though not effective for paroxysmal atrial fibrillation.

    • dofetilide 0.125mg

      (Dofetilide 0.125mg)
      Granules Pharmaceuticals Inc.
      Usage: Dofetilide is indicated for maintaining normal sinus rhythm in patients with atrial fibrillation/atrial flutter who have been converted from AF/AFl and for conversion of AF/AFl to normal sinus rhythm. It is reserved for symptomatic patients due to potential life-threatening ventricular arrhythmias.

    • sotalol hydrochloride

      (Sotalol Hydrochloride Tables AF)
      Bayshore Pharmaceuticals LLC
      Usage: Sotalol AF is indicated for maintaining normal sinus rhythm in symptomatic patients with atrial fibrillation or atrial flutter. It is reserved for those with severe symptoms and is not recommended for easily reversible cases. It also treats life-threatening ventricular arrhythmias but should not be substituted with other sotalol formulations.

    • verapamil hydrochloride

      (verapamil hydrochloride)
      Lifestar Pharma LLC
      Usage: Verapamil Hydrochloride Injection, USP is indicated for rapid conversion to sinus rhythm in paroxysmal supraventricular tachycardias and for temporary control of rapid ventricular rate in atrial flutter or atrial fibrillation. It should be administered in a monitored setting due to potential life-threatening adverse effects.

    • verapamil hydrochloride

      (Verapamil Hydrochloride)
      Zydus Pharmaceuticals USA Inc.
      Usage: Verapamil hydrochloride injection is indicated for rapid conversion to sinus rhythm in paroxysmal supraventricular tachycardias and for temporary control of rapid ventricular rate in atrial flutter or atrial fibrillation, particularly in patients not associated with accessory bypass tracts. Monitoring during administration is advised due to potential serious adverse effects.